Follow-up results from the phase 3 EMBER-3 study showed that, as a monotherapy, Inluriyo demonstrated a 38% reduction in the ...

What’s holding pharma back from true digital transformation? At NEXT Pharma 2025, Our CEO Rob Verheul and Roeland van der ...

Galderma’s Nemluvio (nemolizumab) has shown rapid relief of itch, as well as improvement in sleep, in patients with atopic ...

Virtual Works was founded in 1997 as a formal co-operative of independent professionals, all highly experienced and with a collective and complementary skills base. All of us have been working in ...

When influence outpaces expertise However, the rise of health content on social media has also fuelled the parallel problem ...

The industry is now entering the next era by embedding AI directly into the software field teams’ use every day. The step ...

Organisations that allow AI to operate responsibly at scale can achieve speed and quality gains while remaining compliant.

At Avalere Health, we have identified six crucial elements of a successful launch, driven by insight, integrated working, ...

Health equity is an ambitious goal, but the drive to deliver life-changing innovation to all eligible patients is ...

Building a trusted data foundation The starting line for any successful AI journey is data readiness and quality. Before ...

The 2025 edition of PMLiVE’s T40 list of creative agencies working on advertising, branding, creative and design projects in ...

Nektar Therapeutics has announced top-line results from its trial of rezpegaldesleukin to treat severe to very severe ...